Arkolith/Insider Trading/RPHM/Form 4

Johnson Wendy S.

Chief Development OfficerReneo Pharmaceuticals, Inc. (RPHM) · full profile →Form 4 · filed Jul 15, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$950K
Net Open-Market Flow
-$950K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 14, 2021Sell(S)112K$8.50$950K0

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-046802) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML